Track bills, resolutions, and amendments moving through Congress
Choices for Increased Mobility Act of 2026
The bill clarifies Medicare payment and coding for ultralight wheelchair bases and increases price transparency, but risks higher out‑of‑pocket costs and access barriers for patients and added administrative burdens for suppliers.
Health Care Efficiency Through Flexibility Act
The bill modernizes and pilots more flexible electronic ACO quality reporting—potentially improving measurement and cutting reporting burden—but does so with modest net reductions to Medicare funding, added implementation costs, reduced formal rulemaking oversight, and risks to transparency and equitable participation.
Rural Community Hospital Demonstration Program Reauthorization
The bill extends and broadens support for rural hospitals—helping preserve payments, access, and short-term financial stability for rural communities—at the cost of higher Medicare spending and the risk of delaying broader reforms or diverting resources from other rural health priorities.
Hospital Inpatient Services Modernization Act
The bill continues and studies Medicare Acute Hospital Care at Home—preserving in-home access and generating evidence on quality, cost, and equity—but does so while cutting dedicated improvement funding and extending waivers that raise fiscal and patient-safety risks and delay firm policy conclusions.
Urging the protection of Medicare from the devastating cuts caused by H.R. 1.
The resolution raises awareness and political pressure to protect Medicare and avoid automatic sequestration, but it also underscores that projected deficits could trigger deep, across-the-board cuts that threaten health care access, social safety-net programs, and other federal priorities, forcing difficult trade-offs for taxpayers and vulnerable Americans.
Urging the protection of Medicare from the devastating cuts caused by H.R. 1.
The resolution increases transparency about large projected Medicare shortfalls—helping prompt responses to protect providers—but it also highlights risks that sequestration-driven cuts could reduce benefits for millions, strain health providers, and worsen federal fiscal pressures.
Hearing Device Coverage Clarification Act
The bill expands Medicare coverage and access for implanted middle ear devices, easing costs for beneficiaries and enabling provider billing, while creating modest increases in Medicare spending and near-term implementation burden for CMS and providers.
Medicare Dental, Hearing, and Vision Expansion Act of 2025
The bill significantly expands Medicare benefits for dental, hearing, and vision—improving access and lowering some out‑of‑pocket costs for seniors and people with disabilities—while introducing new cost sharing, payment caps, and administrative complexity that could limit provider participation, constrain choice, and shift costs over time.
COMPLETE Care Act
The bill increases Medicare payments and funds technical assistance to expand integrated behavioral health in primary care—likely improving access for beneficiaries and supporting providers—but raises federal costs and risks uneven uptake that could widen disparities or skew service delivery.
Bipartisan Health Care Act
The bill increases transparency, funding, and public‑health preparedness (notably in drug pricing, community care, and emergency response) that could improve access and accountability for many Americans — but it also imposes substantial reporting, compliance, and privacy tradeoffs and raises fiscal and market‑structure risks that may drive higher costs or consolidation unless carefully implemented.
Patients Before Middlemen Act
The bill increases pharmacy network access and PBM transparency to lower patient drug costs and protect local pharmacies, but it also raises compliance, administrative, and liability costs for plans, PBMs, and CMS that could translate into higher premiums, narrower benefits, or implementation delays.
EPIC Act of 2025
The bill preserves some near-term negotiation benefits for certain drugs in 2026–2027 and shifts negotiation focus to older, better-studied medicines from 2028 onward, but it delays negotiated price relief for many drugs during years 8–11 post-approval — likely raising costs for patients and Medicare while reducing HHS's bargaining leverage.
Finn Sawyer Access to Cancer Testing Act
The bill greatly expands and clarifies coverage and reimbursement for advanced cancer genomic testing and invests in clinician training—improving access and care quality for many—while imposing test-frequency limits, payment caps, and fiscal/state‑level rollout challenges that may leave some patients or providers with added costs and create uneven access.
Protecting Rural Seniors’ Access to Care Act
The bill prevents immediate federal staffing and reporting mandates—reducing provider costs and regulatory burdens—but sacrifices enforceable protections and funding that are most likely to produce timely, widespread improvements in nursing home staffing and resident care, relying instead on an unfunded advisory panel whose recommendations may be slow or hard to implement.
Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025
The bill expands who can prescribe cardiac and pulmonary rehab and clarifies permitted delivery locations—improving access and convenience for Medicare beneficiaries but likely increasing Medicare costs and causing short-term billing/compliance uncertainty for providers.
PLASMA Act
The bill phases in discounted prices for covered plasma-derived biologics that should reduce out-of-pocket costs and create more predictable pricing, but savings arrive gradually and unevenly, while manufacturers and program administrators face revenue and implementation burdens.
More Behavioral Health Providers Act of 2025
The bill expands a targeted 15% Medicare payment bonus to more mental health providers and clinics in shortage areas to improve access for Medicare beneficiaries, at the cost of higher Part B spending, potential mis-targeting of funds, and added administrative complexity.
I CAN Act
The bill expands access to care by empowering non‑physician clinicians and speeding implementation of coverage/payment changes—likely improving timely services and provider participation—but does so at the cost of higher federal/state spending, added administrative burdens, and potential variability or unevenness in quality and state-by-state access.
SOLES Act
The bill provides targeted federal funding to raise Medicare outpatient payments for sole community hospitals in Alaska and Hawaii to preserve services in remote communities, but does so at added federal cost, without reducing patient cost-sharing, excludes many other rural hospitals, and may not deliver immediate relief.
CRITICAL Act
The bill clarifies Medicare treatment for CAH‑related inpatient and linked outpatient/ambulance/post‑acute services in noncontiguous states to help preserve local access, but it leaves funding/timing unclear and may create administrative or reimbursement risks for providers.
Ensuring Outpatient Quality for Rural States Act
The bill raises Medicare OPD payments for Alaska and Hawaii to help sustain outpatient access in high‑cost, remote areas, but does so at increased federal cost and without guarantees that higher payments will improve quality or encourage efficiency.
Supporting Access to Rural Community Hospitals Act of 2025
The bill temporarily allows rural hospitals to obtain CAH status to bolster finances and preserve local inpatient care, at the trade-off of higher Medicare costs, potential limits on some inpatient services, and short-term administrative uncertainty.
Coordinating Care for Senior Veterans and Wounded Warriors Act
The bill pilots private-sector, value-based coordination between VA and Medicare that could improve care coordination and reduce duplication for some dual-enrolled veterans, but it risks shifting care toward private providers, entails upfront costs and possible delays, and initially benefits only a limited number of veterans.
Rural Hospital Closure Relief Act of 2025
The bill helps preserve rural hospital access and short‑term financial stability through temporary CAH conversions, oversight, and study, but does so with capped slots, potential increases in Medicare spending, delayed implementation of broader reforms, and increased operational and administrative uncertainty for some hospitals.
Medicare Cost Cap Act of 2026
The bill improves financial protection and access to subsidies for many Medicare enrollees (notably low‑income and high‑utilization beneficiaries) by capping Part A/B out-of-pocket costs and aligning eligibility, at the expense of higher federal/state program spending, added state administrative burden, and some remaining coverage gaps and transitional complexity.
Alternatives to PAIN Act
The bill improves access to and affordability of certain non-opioid pain medications for Medicare enrollees and reduces opioid exposure, but does so at the risk of higher program and premium costs and reduced payer oversight that could raise safety and cost-shifting concerns.
Improving Access to Medicare Coverage Act of 2026
The bill improves many Medicare beneficiaries' access to Medicare-covered post-acute skilled nursing care by counting observation days as inpatient days, while raising Medicare/taxpayer costs and imposing short-term administrative burdens and possible retroactive-claim barriers for some beneficiaries.
Medicare Access to Radiology Care Act of 2026
The bill expands supervised radiologist assistant roles to speed access and improve practice efficiency and regulatory clarity, at the cost of higher Medicare/taxpayer spending and increased patient confusion and administrative/billing complexity for providers and regulators.
Legalizing Premium Health Care Act of 2026
The bill expands Medicare patients' choice and clarifies administration by allowing advance contracting and a uniform national charge rule, but it risks higher costs for patients and taxpayers, limits state consumer protections, and excludes dual‑eligible beneficiaries from the new contracting option.
Increasing Access to Lung Cancer Screening Act
The bill significantly expands access to lung cancer screening and tobacco‑cessation services—likely improving early detection and quit rates—but does so at increased cost and administrative burden, with risks of capacity strains and some inappropriate use if guidelines or implementation lag clinical evidence.
